Further adoption of TMAs into the clinical laboratory is likely to be driven by adoption of both digital pathology and/or the use of quantitative tissue-based assays. TMAs can serve as useful ...

protein interactions and protein modifications in fixed cells and tissue samples. The Duolink ® immunoassay reagents are based on the in situ proximity ligation assay, capable of reporting ...

The integration will enable Leica’s BOND staining systems to simultaneously detect RNA and protein targets on the same tissue.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, today, at the 43rd annual J.P. Morgan Healthcare Conference. In addition to ...